Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Rupikang
- Development stage
- Unknown
- Lead developer
- Dalian Aosen Pharmaceutical
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Rupikang is a Chinese Patent Medicine (CPM) developed and manufactured by Dalian Aosen Pharmaceutical (and its subsidiary Dalian Mingsen Pharmaceutical). It is an oral capsule formulation primarily indicated for the treatment of mammary gland hyperplasia (fibrocystic breast changes), mastalgia (breast pain), and breast nodules. In the framework of Traditional Chinese Medicine (TCM), it is used to 'soften hardness and dissipate knots' by addressing phlegm-dampness and qi stagnation. Pharmacologically, Rupikang is believed to regulate the endocrine system, specifically by modulating the balance between estrogen and progesterone, thereby inhibiting the pathological proliferation of mammary tissue. Its herbal composition typically includes ingredients such as *Laminaria japonica*, *Prunella vulgaris*, and *Astragalus membranaceus*.
- Brand names
- Rupikang
- Other names
- Rupikang capsule乳癖康胶囊
Beyond the preview
Go deeper on Rupikang.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Rupikang.